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Objectives. To develop classification algorithms that accurately identify axial spondyloarthritis 
(axSpA) patients in electronic health records (EHR), and compare the performance of algorithms 
incorporating free-text data against approaches using only International Classification of Diseases 
(ICD) codes. 
Methods. An enriched cohort of 7,853 eligible patients was created from EHR of two large hospitals 
using automated searches (≥1 ICD codes combined with simple text searches). Key disease concepts 
from free-text data were extracted using natural language processing (NLP) and combined with ICD 
codes to develop algorithms. We created both supervised regression-based algorithms - on a 
training set of 127 axSpA cases and 423 non-cases - and unsupervised algorithms to identify patients 
with high probability of having axSpA from the enriched cohort. Their performance was compared 
against classifications using ICD codes only. 
Results. NLP extracted four disease concepts of high predictive value: ankylosing spondylitis, 
sacroiliitis, HLA-B27 and spondylitis. The unsupervised algorithm, incorporating both the NLP 
concept and ICD code for AS, identified the greatest number of patients. By setting the probability 
threshold to attain 80% positive predictive value, it identified 1,509 axSpA patients (mean age 53 
years, 71% male). Sensitivity was 0.78, specificity 0.94 and area under the curve (AUC) 0.93. The two 
supervised algorithms performed similarly but identified fewer patients. All three outperformed 
traditional approaches using ICD codes alone (AUC 0.80 to 0.87). 
Conclusion. Algorithms incorporating free-text data can accurately identify axSpA patients in EHR. 
Large cohorts identified using these novel methods offer exciting opportunities for future clinical 
research. 
Keywords: classification, phenotyping, electronic health records, free-text, natural language 
processing, machine learning, axial spondyloarthritis, ankylosing spondylitis, ICD code 
Key messages: 
1. Algorithms incorporating free-text data improve the accuracy for classifying axSpA patients 
in EHR. 
2. A robust axSpA algorithm could be developed without training on chart-reviewed cases. 






A key step in any clinical research is identifying a group of people with a disease of interest. This can 
be labour-intensive, particularly for relatively uncommon conditions such as axial spondyloarthritis 
(axSpA). Due to its low prevalence (0.7% in the United States (1)), the majority of axSpA studies use 
specialised registries or small prospective cohorts. Rare outcomes, or those not recorded by 
registries, often cannot be studied in sufficient detail. Electronic health records (EHR) are 
increasingly used world-wide and contain vast amounts of real-world data on millions of patients. 
They provide opportunities to create relatively large cohorts that can meet these research needs. 
Accurately identifying, or classifying, axSpA patients from EHR can be challenging. A common 
approach is rule-based; for example, requiring a certain number of International Classification of 
Disease (ICD) or other diagnostic codes (2,3). Performance of these methods depend on the codes’ 
accuracy, which can vary substantially across healthcare systems (4). Applying more strict rules may 
improve accuracy among those classified as cases, but will reduce the number and 
representativeness of patients identified. Moreover, ICD codes may not be well defined for evolving 
disease concepts such axSpA where there are no specific codes up to the 10th version. 
For several chronic diseases including rheumatoid arthritis, classification algorithms have been 
improved by supplementing codified data with information from free-text, or “narrative”, EHR data 
(e.g., healthcare provider notes) using natural language processing (NLP) (5–9). NLP tools have been 
developed and successfully applied to identify clinical concepts (10). In contrast to a search for 
keywords, NLP can distinguish positive/negative mentions of concepts (e.g., between “sacroiliitis” 
and “no sacroiliitis”) and each concept can include several ways of expressing meaning. NLP-assisted 
algorithms were more accurate, and identified more patients, than those using codified data alone 
(11). They also permit phenotyping of diseases without ICD codes.  
We aimed to develop novel algorithms incorporating both codified and narrative data to identify 
axSpA patients in EHR, and to compare them against traditional approaches using only ICD codes.  
 
Methods 
A flow-chart summary of the algorithm development process is shown in figure 1. Hereinafter, an 
algorithm is described as “supervised” if it is trained using labelled data derived from manual chart-
review, and “unsupervised” if it leverages inherent structures in the data without requiring labels. 
Data source and enriched cohort 
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We used data from the Partners HealthCare EHR from two large tertiary care hospitals in Boston, 
USA. Both have been using EHRs for approximately two decades, and through that time provided 
care for approximately 7.4 million patients. 
To develop the algorithms, we adapted a standardized phenotyping process using NLP and machine 
learning (12). Including all patients in the EHR would substantially limit the accuracy of a 
classification algorithm, since positive predictive value (PPV) is dependent on prevalence. The 
process therefore starts by applying screening criteria to create an enriched cohort of patients who 
may potentially have axSpA, while excluding those with very low probability of the condition. We 
applied the following screening criteria: ≥1 ICD-9 or 10 codes for ankylosing spondylitis (720.x or 
M45.x; collectively referred to as “ICD codes” henceforth) or any mention of AS in the discharge or 
ambulatory notes. There are no ICD codes specifically for axSpA. Prior studies showed that “AS” was 
used synonymously with axSpA in Partners EHR (13). We also required patients to have “SI joint”, 
“syndesmophyte” or words beginning with “sacroil-” in clinical notes or radiology reports. Subjects 
under 18 years of age were excluded. Remaining individuals formed the enriched cohort, among 
whom algorithm development and evaluation were performed. This study was approved by the 
Partners Institute Review Board. 
Codified data 
The total number of ICD codes for AS ≥7 days apart were counted for each patient. We also 
measured healthcare utilization as the number of medical encounters in each patient’s EHR, such as 
a physician visit or visit for an outpatient investigation. 
Selecting informative disease concepts from narrative data 
Healthcare professional use various terminologies and phrasing to express the same clinical meaning. 
For instance, “inflammation of the right sacroiliac joint”, “left sacroiliac joint arthritis” and “bilateral 
sacroiliitis” all refer to sacroiliitis. NLP can map these linguistic variations to the specific concept 
“sacroiliitis” by linking to the Unified Medical Language System (UMLS) (14), while disregarding 
negative mentions such as “no evidence of sacroiliitis” (15). 
We follow the previously published Surrogate-Assisted Feature Extraction (SAFE) method to 
generate a list of candidate axSpA concepts to extract from narrative EHR notes (11). The SAFE 
approach begins by identifying a list of potential concepts from online resources (e.g., Medline and 
Medscape) that is equivalent or better for classification algorithms compared to lists curated by 
clinical domain experts (11). We then processed free-text clinical notes using NLP to count the 
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number of positive mentions of each axSpA concept for each patient. Healthcare provider notes, 
discharge summaries and radiology reports in typed format were used; scanned notes were not.  
To select the most informative concepts from this list, least absolute shrinkage and selection 
operator (LASSO) penalized logistic regression was fitted to each of three surrogate labels against all 
candidate concepts repeatedly (11). LASSO penalized regression performs selection by assigning the 
coefficients of non-informative concepts to zero. We constructed three surrogate labels using AS ICD 
code, AS NLP concept or a rule-based criterion with known high PPV (13) as proxies for the true 
axSpA label (11). Concepts that were selected >50% of the time were retained and combined with 
codified data for subsequent supervised algorithm training. The SAFE method has been shown to 
reduce overfitting and improve model performance (11). 
Gold-standard training labels 
From the enriched cohort, we randomly selected 550 individuals whose records were reviewed by a 
rheumatologist. They were categorised into either 1) definite axSpA: meeting full or pragmatic 
versions (13) of the modified New York (16) or Assessment of Spondyloarthritis international Society 
(ASAS) classification criteria (17), or 2) insufficient or no evidence from radiology reports or medical 
notes for axSpA classification criteria. This process has been previously described (13) and is shown 
in Supplementary Figure 1. Algorithms were trained to identify cases of axSpA meeting research 
classification criteria. 
Algorithm training and evaluation 
We developed three algorithms using: 1) logistic regression including all variables selected by SAFE, 
which optimises model fit at potential cost to overfitting, 2) LASSO penalized logistic regression, 
which further reduces the number of variables in the model and optimises external validity, and 3) a 
multimodal automated phenotyping (MAP) approach (18). The first two supervised algorithms were 
developed using the gold-standard labels. MAP is an unsupervised approach that classifies 
phenotypes in EHR data without requiring labels from manual chart-review (18). Instead, it is trained 
by combining information from three key variables (AS ICD code, AS NLP concept and healthcare 
utilisation) using the entire enriched cohort. 
Comparing against the chart-review gold-standard, performance characteristics of each algorithm 
was reported using the area under the receiver operating characteristic curve (AUC), PPV, sensitivity, 
specificity and the F-score (harmonic mean of PPV and sensitivity). We chose 80% PPV as the 
threshold to allow consistent comparison across the algorithms, based on the maximum PPV in the 
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majority of similar axSpA studies (2,3,19). Cross-validation with 70:30 splits averaged over 100 
random partitions was used to correct for over-fitting bias in estimating accuracy measures.  
The algorithms assigned each patient their probability of having axSpA; those with probabilities 
above a threshold that achieves 80% PPV were classified as having axSpA. Performance of the NLP-
assisted algorithms was compared against classification using only ICD-codes. A logistic regression 
model was created with the number of AS ICD codes as the only predictor. We also classified 
patients as having axSpA if they had ≥2 or ≥3 AS ICD codes. We used established phenotyping 
packages (12,18) in R version 3.5.0 for algorithm development, and Stata v14 for all other analyses. 
 
Results 
A total of 7,853 patients passed the initial screening criteria to form the enriched axSpA cohort. Of 
the 550 patients randomly sampled from this cohort, 127 (23%) were determined to have axSpA 
meeting classification criteria after manual chart-review and 423 did not. Clinical characteristics and 
distributions of codified and narrative data are shown in Table 1. axSpA cases had higher counts of 
AS ICD codes and AS NLP concepts (P<0.001). They were also more frequently male (83 vs 46%, 
P<0.001). 263 patients had ≥1 AS ICD codes, among whom 113 (43%) met classification criteria for 
axSpA. 
Six disease concepts were selected by the SAFE procedure. The logistic regression model used all 6 
concepts; the most informative was the NLP concept for AS, followed by the AS ICD code, and NLP 
concepts for sacroiliitis, HLA-B27 and spondylitis, in order of predictive value (Table 2). In the LASSO 
model, all variables except the NLP concept for spondylitis were retained. The MAP model by design 
requires the AS ICD code and NLP concept and does not provide coefficients. 
When all three algorithms were applied to the enriched cohort, MAP had the highest sensitivity and 
identified the greatest number of patients (Table 3). With probability threshold set to provide 80% 
PPV, MAP identified 1,509 patients as having high probability of axSpA with 78% sensitivity and 94% 
specificity. Performances of the three NLP-assisted algorithms were otherwise similar and all out-
performed classification using ICD codes (Table 3).  
Characteristics of 1,509 patients identified by the MAP algorithm are shown in Supplementary Table 
1. These patients were younger (53 vs 57 years), more frequently male (71 vs 48%), and had higher 
counts of AS ICD codes (median 6 vs 0) and AS NLP concepts (median 25 vs 1), compared to those 





The ability to accurately and efficiently classify diseases in EHR has significant implications for clinical 
research. We showed that evolving disease concepts such as axSpA, where no specific ICD codes are 
available, can be accurately identified in EHR by incorporating narrative data using NLP. The MAP 
algorithm demonstrated high sensitivity (78%) and specificity (94%) and, notably, was developed 
without the need for manually derived training labels or domain experts to identify predictive 
disease concepts. These algorithms allow large cohorts of even uncommon diseases to be generated 
from EHR to facilitate clinical research. 
Comparing our algorithms against those from prior studies is challenging, since PPV (the main 
performance measure of interest) depends on prevalence of axSpA in each study and the disease 
definition used. The accuracy of AS ICD codes was assessed in 184 patients with ≥2 rheumatology 
visits from the Veterans Affairs (VA) EHR. The prevalence of AS was 7%. Among 11 patients with ≥1 
AS ICD codes, 10 had rheumatologist diagnosed AS; accordingly the PPV was 91% and sensitivity 83% 
(20). As the authors noted, this was unexpectedly high compared to parallel studies in RA (PPV 66%); 
the small sample size may be one explanation. Two European studies reported performance 
characteristics only among classification-positive patients; that is, patients not classified as cases 
(and therefore prevalence/sensitivity) were not reported. Among 85 UK primary care patients who 
had ≥1 Read codes for AS, 58 (PPV 68%) had AS according to rheumatologist diagnosis; PPV for 
classification criteria axSpA was 72% (3). A Swedish study of 250 patients from rheumatology 
departments found that PPV for classification criteria axSpA was 79% among those with ≥1 AS ICD 
codes (2). 
While our cohort and case-definitions were not directly comparable to the above studies, the 
accuracy of AS ICD codes in our EHR was generally lower. In the US, 26 to 53% of axSpA diagnoses 
are made by primary care physicians, and up to 63% are diagnosed outside of rheumatology 
practices (21,22). Since the accuracy of these codes can be very low (21), the proportion of ICD 
codes assigned by non-rheumatologists will determine overall accuracy. 
The need for improved methods of identifying axSpA patients in EHR was highlighted by the low 
estimated prevalence (23%) of axSpA despite the initial enrichment process, which used ICD codes 
and ‘keyword searches’ in clinical notes and radiology reports. Unlike NLP, the results of a keyword 
search cannot distinguish negative mentions which may be more common; for example, absence of 
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sacroiliitis is commonly reported during investigation of back pain. AS may also be included in lists of 
differential diagnoses and check lists (e.g., pre-operative anaesthetic assessment). 
Compared to the above rule-based methods, an advantage of our algorithm is that the probability 
threshold to classify a case can be tailored according to the needs of the research question. Higher 
PPVs can be selected at the expense of sensitivity. Our classification process has several additional 
strengths through each step of its development. From the outset, records from all patient were used, 
not just those under rheumatologists. This is important since a significant proportion of axSpA 
patients are diagnosed and managed in primary care only (22,23) but may attend hospital for other 
reasons. In forming the enriched cohort, we included not only individuals with AS ICD codes but also 
those with mention of the disease in notes, which is important since it was previously shown that 43% 
of axSpA patients did not have an AS ICD code (19). In our chart-reviewed sample, 11% of those with 
axSpA did not have AS ICD codes. These features allow many more potential cases to be found. 
One rate-limiting step in the development of any classification algorithm is identifying informative 
disease concepts. In a prior study involving complex and labour-intensive steps, the same axSpA 
concepts were found as in our study: HLA-B27, sacroiliitis, and terms with the prefix “spond-” (24). 
We selected axSpA concepts using an automated process without dependence on expert input, with 
the final list reviewed by an expert for face validity. Furthermore, the MAP algorithm had superior 
performance without using these additional concepts at all. The “spondylitis” concept may be of 
greater predictive value in healthcare systems where “axSpA” is more widely used. Another major 
bottleneck in algorithm development is the time-consuming chart-review required to create the 
gold-standard training labels. The MAP algorithm achieved similar predictive performance without 
the need for these labels. 
Accurately and efficiently identifying diseases in EHR offers exciting opportunities for clinical 
research. Linking EHR and biobanks have allowed large-scale studies of biomarkers (5,25) or genetic 
variants (26,27) against a broad range of phenotypes. NLP can also improve identification of disease 
outcomes (7). Large, real-world cohorts can be used to study healthcare utilisation (13) or rarer 
outcomes overlooked by prospective registries.  
Developing a classification algorithm in the context of evolving terminology is challenging. The 
concept of AS has expanded over the past decade to include non-radiographic, potentially early, 
forms of the disease (17). The terms “axial spondyloarthritis” and “non-radiographic axial 
spondyloarthritis” were uncommon in our EHR because: 1) EHR started before the ASAS criteria was 
introduced, and 2) the 9th and 10th versions of ICD codes do not include axSpA. One limitation is that 
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we used NLP concept and ICD code for AS to identify axSpA patients, although our prior work 
showed that “AS” was used synonymously with axSpA (13). Equally, our approach has the advantage 
of allowing researchers to identify diseases that cannot be captured using ICD codes alone. Linguistic 
variations can be captured using concepts in the UMLS, which may have limited vocabulary coverage 
in other languages. Another limitation was that our algorithm was developed using EHR from a single 
healthcare system. Not all EHR systems may be able to provide data used in our development 
process, such as word-searches in the initial enrichment process. The prevalence of axSpA may also 
be lower in smaller centres or higher in those providing specialist axSpA services. Although similar 
algorithms for RA developed using the same approach were shown to be portable (28), further 
studies to externally validate our axSpA algorithm in different EHR systems and other countries are 
needed. Chart-review for the training set was performed by one rheumatologist. The purpose was to 
extract documented diagnoses and criteria components, rather than making subjective decisions on 
whether a case was axSpA that would necessitate a second reviewer.  
In conclusion, we demonstrated that classification algorithms incorporating narrative EHR data and 
machine learning can accurately identify evolving disease concepts such as axSpA. The automated 
MAP algorithm allows large cohorts of even uncommon diseases to be efficiently created, offering 
exciting opportunities for future clinical research. 
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Figure 1. Process of algorithm development for classifying axial spondyloarthritis (axSpA) patients in 
electronic health records (EHR). First, search filters were applied to create an enriched cohort of 
patients who may potentially have axSpA. Second, an automated process identified informative NLP 
disease concepts which, together with codified data, formed variables in the predictive models. Only 
the two supervised algorithms involved the third step: manual chart-review of a random sample of 
patients to created gold-standard training labels. The unsupervised algorithm did not require labels 
for training. Finally, each of the three algorithms was applied to the enriched cohort to identify 





Table 1. Patient characteristics of the training set and distributions of their codified and 
narrative data. 
 axSpA cases Controls P-value 
N 127 423  
Age, years 51.7 (18.4) 55.4 (19.0) 0.055 
Male 106 (83%) 196 (46%) <0.001 
Race White 110 (87%) 356 (84%) 0.800 
African American 12 (3%) 3 (2%) 
Other 55 (13%) 14 (11%) 
HLA-B27 tested 50 (39%) 89 (21%) <0.001 
HLA-B27 positive 40 (80%) 47 (53%) <0.001 
Uveitis 30 (24%) 23 (5%) <0.001 
Psoriasis 5 (4%) 38 (9%) 0.063 
IBD 10 (8%) 16 (4%) 0.057 
Number of ICD codes for AS 7 (2, 13) 0 (0, 1) <0.001 
Number of AS concepts  21 (8, 59) 1 (0, 4) <0.001 
Number of sacroiliitis concepts 1 (0, 7) 0 (0, 1) <0.001 
Number of HLA-B27 concepts 1 (0, 6) 0 (0, 1) <0.001 
Number of spondylitis concepts 2 (0, 6) 0 (0, 1) <0.001 
Rheumatologist diagnosis of AS 127 (100%) 62 (15%) - 
Data shown as mean (standard deviation), number (percentage) or median (interquartile range).  
axSpA, axial spondyloarthritis; AS, ankylosing spondylitis or radiographic axSpA; ICD, 
International Classification of Diseases - versions 9 and 10; IBD, inflammatory bowel disease. 
 
Table 2. Standardised model coefficients indicating each variable’s 
predictive value. 
 Logistic regression LASSO 
ICD codes for AS 0.99 0.99 
NLP for AS 1.24 1.18 
NLP for sacroiliitis 0.48 0.35 
NLP for HLA-B27 0.24 0.01 
NLP for spondylitis  0.21  
Healthcare utilisation -0.45 -0.43 
ICD, International Classification of Diseases - versions 9 and 10; 







Table 3. Performance characteristics of NLP-assisted and ICD-code based classification 
methods. 
 Number of 
axSpA cases 
identified 





MAP 1,509 0.927 80* 78 94 79 
LASSO 1,272 0.929 80* 71 95 75 
Logistic 
regression 
1,281 0.930 80* 70 95 75 
ICD code 
count 
981 0.870 78* 63 95 70 
≥2 ICD codes 1,881 0.804 60 76 84 67 
≥3 ICD codes 1,381 0.802 69 70 90 69 
Performance characteristics were derived using cases fulfilling classification criteria as the 
gold-standard. 
*PPV was selected to be approximately 80%; probability threshold can be adapted to 
provide PPVs according to study requirements. 
ICD, International Classification of Diseases - versions 9 and 10; NLP, concept derived from 
narrative data using natural language processing; axSpA, axial spondyloarthritis; AUC, area 
under the ROC curve; MAP, multimodal automated phenotyping; PPV, positive predictive 
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